---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-21-336764"
form_type: "8-K"
ticker: "ORGO"
cik: "0001661181"
company_name: "Organogenesis Holdings Inc."
filed_at: "2021-11-22T23:59:59+00:00"
generated_at: "2026-06-28T06:08:48.618397+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Organogenesis appoints Prathyusha Duraibabu to board, regains Nasdaq audit committee compliance

## Summary
- Prathyusha Duraibabu appointed independent director effective Nov 19, 2021; also joins audit committee.
- Board now has eight members; appointment restores compliance with Nasdaq Listing Rule 5605(c)(2)(A).
- Ms. Duraibabu received 11,340 RSUs vesting in equal annual installments over three years.
- She is CFO of Sangamo Therapeutics; brings 24+ years in tech/healthcare and CPA qualification.

## SEC filing metadata
- accession: 0001193125-21-336764
- form_type: 8-K
- ticker: ORGO
- cik: 0001661181
- company_name: Organogenesis Holdings Inc.
- filed_at: 2021-11-22T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1661181/000119312521336764/0001193125-21-336764-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1661181/000119312521336764/d210033d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-21-336764
- JSON: https://secwatch.observer/filing/0001193125-21-336764.json
- Plain text: https://secwatch.observer/filing/0001193125-21-336764.txt

## Key facts
- Executive change
  Prathyusha Duraibabu was appointed as Independent Director at Organogenesis Holdings Inc..
  - Action: appointed
  - Role: Independent Director
  source text: Prathyusha Duraibabu had been appointed by the board of directors to serve as an independent director of the Company effective as of November 19, 2021.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1661181/000119312521336764/0001193125-21-336764-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.